Drug Profile
Research programme: drug discovery - Sumitomo Pharma/Kyoto University
Latest Information Update: 05 Apr 2022
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma; Kyoto University
- Developer Kyoto University; Sumitomo Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified